Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Prelude Therapeutics (PRLD) Leases (2024 - 2025)

Prelude Therapeutics (PRLD) has disclosed Leases for 2 consecutive years, with $27.2 million as the latest value for Q4 2025.

  • Quarterly Leases fell 5.35% to $27.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $27.2 million through Dec 2025, down 5.35% year-over-year, with the annual reading at $27.2 million for FY2025, 5.35% down from the prior year.
  • Leases hit $27.2 million in Q4 2025 for Prelude Therapeutics, down from $27.5 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $30.1 million in Q1 2024 to a low of $27.2 million in Q4 2025.